Clinically, elevated CXCL9/CXCL10 levels have been detected in the serum of patients with ICI-induced arthritis [38] and in lesional skin biopsies from those with immunotherapy-related dermatitis [40], directly linking this chemokine to irAE pathogenesis across organs. Here, CXCL10 is linked to arthritic joint disease.